Kaltenböck, A <br/><br/>
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.  [electronic resource] 

 -  Vaccine  Jul 2009 
 - 4483-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2009.05.034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Encephalitis, Japanese--immunology<br/>Female<br/>Hepatitis A--immunology<br/>Hepatitis A Antibodies--blood<br/>Hepatitis A Vaccines--administration & dosage<br/>Humans<br/>Japanese Encephalitis Vaccines--administration & dosage<br/>Male<br/>Single-Blind Method<br/>Vaccines, Inactivated--administration & dosage<br/>Young Adult